ARNABOLDI, LORENZO
 Distribuzione geografica
Continente #
AS - Asia 4.219
EU - Europa 3.956
NA - Nord America 3.635
SA - Sud America 297
AF - Africa 78
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.219
Nazione #
US - Stati Uniti d'America 3.467
CN - Cina 1.974
GB - Regno Unito 1.390
IT - Italia 850
SG - Singapore 843
DE - Germania 388
HK - Hong Kong 321
VN - Vietnam 264
RU - Federazione Russa 263
SE - Svezia 235
BR - Brasile 210
IN - India 202
FR - Francia 173
NL - Olanda 128
KR - Corea 121
JP - Giappone 120
TR - Turchia 119
CA - Canada 113
IE - Irlanda 86
FI - Finlandia 84
UA - Ucraina 76
ES - Italia 58
BD - Bangladesh 57
ID - Indonesia 57
EU - Europa 44
DK - Danimarca 40
MX - Messico 35
CH - Svizzera 34
AT - Austria 29
AR - Argentina 25
AU - Australia 24
BE - Belgio 22
CO - Colombia 21
TW - Taiwan 21
CI - Costa d'Avorio 20
GR - Grecia 20
PL - Polonia 17
PH - Filippine 16
IQ - Iraq 13
HR - Croazia 11
LB - Libano 11
RO - Romania 11
SA - Arabia Saudita 11
TH - Thailandia 11
ZA - Sudafrica 11
PK - Pakistan 10
VE - Venezuela 10
HU - Ungheria 9
RE - Reunion 9
SC - Seychelles 9
CL - Cile 8
EC - Ecuador 8
MY - Malesia 7
TN - Tunisia 7
IL - Israele 6
PY - Paraguay 6
DZ - Algeria 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
UZ - Uzbekistan 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
HN - Honduras 4
JM - Giamaica 4
JO - Giordania 4
KE - Kenya 4
XK - ???statistics.table.value.countryCode.XK??? 4
AL - Albania 3
BJ - Benin 3
EG - Egitto 3
IR - Iran 3
KW - Kuwait 3
PA - Panama 3
PE - Perù 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
CU - Cuba 2
EE - Estonia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NP - Nepal 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
AO - Angola 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GY - Guiana 1
Totale 12.247
Città #
Southend 1.285
Singapore 501
Milan 351
Ashburn 310
Beijing 266
Hong Kong 266
Chandler 228
Fairfield 187
San Jose 162
Seattle 153
Shanghai 143
Boise 138
Wilmington 125
Guangzhou 121
Dallas 111
Ann Arbor 108
Council Bluffs 108
Princeton 101
Frankfurt am Main 85
Nanjing 85
Dublin 84
Redwood City 84
New York 81
Woodbridge 81
Santa Clara 73
Los Angeles 72
Hanoi 71
Ho Chi Minh City 69
Changsha 64
Houston 62
Boardman 58
Mountain View 57
Cambridge 56
Dearborn 56
Hanover 53
Jinan 52
Redmond 51
Lauterbourg 50
Bengaluru 45
Tokyo 39
Buffalo 38
Hefei 38
Moscow 38
Hangzhou 37
Helsinki 35
Wuhan 35
Jacksonville 34
Sakarya 33
Shenyang 33
Des Moines 32
Chengdu 31
Jakarta 31
Grafing 30
Serra 29
Tianjin 29
Toronto 29
Nanchang 27
Rome 25
Hebei 24
Phoenix 23
Seoul 23
Zhengzhou 23
Atlanta 21
Istanbul 21
Shenzhen 21
Abidjan 20
San Diego 20
Chongqing 18
Eitensheim 18
Montreal 17
Athens 16
Cangzhou 16
Columbus 16
Mumbai 16
Munich 16
Ningbo 16
São Paulo 16
Andover 15
Bogotá 15
Brussels 15
Jiaxing 15
Somerville 15
The Dalles 15
Dong Ket 14
Genoa 14
Graz 14
Haiphong 14
Qingdao 14
Berlin 13
Fuzhou 13
Orem 13
Suzhou 13
Chicago 12
Da Nang 12
Magenta 12
Salt Lake City 12
Nuremberg 11
Payette 11
Trieste 11
Xi'an 11
Totale 7.341
Nome #
PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor 2.462
LIPA gene mutations affect the composition of lipoproteins: Enrichment in ACAT-derived cholesteryl esters 587
Effect of valsartan on angiotensin II-induced plasminogen activator inhibitor-1 biosynthesis in arterial smooth muscle cells 442
ABCA1 and HDL3 are required to modulate smooth muscle cells phenotypic switch after cholesterol loading 328
Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome 312
The dataset describes : phenotypic changes induced by cholesterol loading in smooth muscle cells isolated from the aortae of C57BL/6 mice 289
Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency 271
Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1 269
Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100 268
Pharmacological control of the mevalonate pathway: Effect on arterial smooth muscle cell proliferation 240
Oxidized LDL-dependent pathway as new pathogenic trigger in arrhythmogenic cardiomyopathy 238
Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits 237
ABCA1 and HDL3 are required to modulate smooth muscle cells phenotypic switch after cholesterol loading 237
Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection 237
ASGR1 deficiency diverts lipids toward adipose tissue but results in liver damage during obesity 236
Inhibition of smooth muscle cell migration and proliferation by statins 235
NITRIC OXIDE-DONATING STATINS EXERT BENEFICIAL EFFECTS ON ACUTE VASCULAR INFLAMMATION IN NORMOCHOLESTEROLEMIC RABBITS 233
Fibrillar collagen inhibits cholesterol biosynthesis in human aortic smooth muscle cells 231
Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastic differentiation 227
In vitro and in vivo studies of antiatherosclerotic properties of everolimus 219
Cyclosporine a impairs the macrophage reverse cholesterol transport in mice by reducing sterol fecal excretion 219
Everolimus affects cholesterol homeostasis in macrophages 213
Free cholesterol alters macrophage morphology and mobility by an ABCA1 dependent mechanism 195
Effect of S(-) perillic acid on protein prenylation and arterial smooth muscle cell proliferation 195
Statins effect on smooth muscle cell proliferation 193
ABCA1 and HDL3 are Required to Modulate Smooth Muscle Cells Transdifferentiation in a Myocardin-miR143/145-Dependent Process 190
Direct Effects of Statins on the Vascular Wall 187
Nitric Oxide-Donating Atorvastatin Attenuates Neutrophil Recruitment During Vascular Inflammation Independent of Changes in Plasma Cholesterol 182
Controle pharmacologique de la voie de biosynthese du mevalonate: effet sur la proliferation de cellules musculaires lisses arterielles 180
ApoA-I deficiency in apoe-ko mice severely alters lymph nodes and modulates T lymphocyte subsets 174
Serum from hypercholesterolemic patients treated with atorvastatin or simvastatin inhibits cultured human smooth muscle cell proliferation 173
Direct vascular effects of HMG-CoA reductase inhibitors 172
Do structural differences in statins correlate with clinical efficacy? 165
Sera from patients treated with fluvastatin XL inhibit human arterial myocyte proliferation 160
EFFECT OF THE NEW HMG-CoA REDUCTASE INHIBITOR CERIVASTATIN (BAY W 6228) ON MIGRATION, PROLIFERATION AND CHOLESTEROL SYNTHESIS IN ARTERIAL MYOCYTES 158
Pleiotropic effects of statins in atherosclerosis and diabetes 158
Farmacologia delle statine: evidenze di un'azione antiaterosclerotica diretta 147
The pharmacological control of the mevalonate pathway regulates arterial smooth muscle cell proliferation 143
Pharmacological control of myocyte proliferation by different farnesyltransferase inhibitors 137
Valsartan inhibits Ang-II-induced Tissue Factor expression in rat aortic smooth muscle cells 125
Effect of statins beyond lowering cholesterol: Where do we stand? 125
Plasma lipoproteins of patients with genetic LAL deficiency are enriched in cholesteryl esters: Relevance of cholesterol esterification by LCAT 125
Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin 125
Farmacologia della sintesi dei lipidi 120
Proteomics Studies Suggest That Nitric Oxide Donor Furoxans Inhibit In Vitro Vascular Smooth Muscle Cell Proliferation by Nitric Oxide-Independent Mechanisms 119
Artichoke and bergamot extracts: a new opportunity for the management of dyslipidemia and related risk factors 119
Pharmacological control of the mevalonate pathway in the regulation of arterial myocyte proliferation 114
Pharmacological control of protein prenylation and arterial smooth muscle cell proliferation 114
Farnesol and geranylgeraniol prevent the inhibition elicited by simvastatin on proliferation and actin polymerization in rat arterial smooth muscle cells 113
Inhibitory effect of Valsartan on Ang-II-induced Tissue Factor expression in rat aortic smooth muscle cells 104
Drosophila model targets Eiger/TNFα to alleviate obesity-related insulin resistance and macrophage infiltration 95
Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma 86
How We Treat Dyslipidemia in Prolonged Nephrotic Syndrome 57
Totale 12.680
Categoria #
all - tutte 30.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021250 0 0 0 0 0 0 0 0 0 0 165 85
2021/20221.262 127 119 97 96 99 111 88 87 160 90 52 136
2022/2023953 94 90 85 109 91 165 54 59 98 20 43 45
2023/20241.141 89 52 115 90 232 96 42 60 48 88 110 119
2024/20251.754 75 173 52 157 123 81 67 182 125 192 131 396
2025/20262.896 340 208 333 237 272 225 366 170 301 208 236 0
Totale 12.680